Delivery Order SPE2DB20D3303-SPE2DB24FA3CH

Award Date 9/16/24
Potential Completion Date 9/17/24
Potential Value $7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract, valued at $10,394.69, is for the supply of ORENCIA CLICKJECT 125 MG/MLML, a specialty pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp with a...
This federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp is for the delivery of Orencia ClickJect 125 mg/mL, a pharmaceutical product. The $3,892.39 firm-fixed-price delivery order has a completion date of May 14, 2025. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical for the global supply of pharmaceutical products and...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $6,776.20 fixed-price delivery order is for ORENCIA CLICKJECT 125 MG/MLML, a pharmaceutical product. The contract has an ultimate completion date of March 6, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,640.93 delivery order contract is for the supply of Orencia Clickject 125 mg/ml, a pharmaceutical product, with a period of performance through April 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $32,142.37 contract is for the delivery of Orencia ClickJect 125 mg/ml medication to support military treatment programs and facilities. This delivery order contract is part of a larger indefinite delivery contract (IDC) valued at up to...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $13,491.42 to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of ORENCIA CLICKJECT 125 MG/ML. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA...
The U.S. Defense Logistics Agency (DLA) awarded a $21,204.80 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of ORENCIA CLICKJECT 125 MG/MLML, a pharmaceutical product, with a performance period through July 19, 2024. AmerisourceBergen, a major pharmaceutical distributor, is providing these critical medical supplies to support the healthcare needs of military treatment facilities and federal agencies. The...
This is a delivery order worth $13,829.40 awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Orencia ClickJect 125 mg/mL medication. The delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA to provide a comprehensive range of pharmaceutical products and medical supplies to support military treatment programs...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,991.78 firm fixed-price delivery order is for the supply of ORENCIA CLICKJECT 125 MG/MLML, a pharmaceutical product. The contract has an ultimate completion date of March 24, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a $6,597.35 firm-fixed price delivery order to AmerisourceBergen Drug Corp's Corporate Office division for the supply of ORENCIA CLICKJECT 125 MG/MLML pharmaceutical products. This award is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999 through December 2025, which enables the government to efficiently procure a comprehensive range of medical commodities to support...
  • SPE2DB20D3303
    Indefinite Delivery Contract
  • SPE2DB20D3303-SPE2DB24FA3CH
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a $6,998.08 firm fixed-price delivery order contract to AmerisourceBergen Drug Corporation's Corporate Office division for the supply of Orencia ClickJect 125 mg/ml pharmaceutical products. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical for providing a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract has no set-aside designation and is scheduled for completion by September 17, 2024. As a major pharmaceutical distributor, AmerisourceBergen leverages its extensive supply chain to deliver critical prescription medications, medical supplies, and equipment to various federal healthcare providers.

Generated 12/16/24, 2:06 PM